Utilisateur
Function is dictated by structure; 3D structure is determined by primary (1°) sequence.
Myoglobin (Mb) is a monomer (no 4°). Hemoglobin (Hb) is an oligomer (4°).
Hb binds O₂ in lungs and releases in tissues; Mb binds O₂ in muscle cells.
Facilitates O₂ diffusion, local O₂ reserve during intense exercise, O₂ storage in aquatic animals.
Dissociation constant:
K
d
=
[
P
]
[
L
]
[
P
L
]
K
d
=
[PL]
[P][L]
; lower Kd = higher affinity.
Hyperbolic (fractional saturation vs [ligand]).
Affinity (Kd); lower Kd reaches saturation at lower [ligand].
153 aa, 8 α-helices, heme in hydrophobic pocket between E & F helices.
Planar porphyrin with Fe²⁺ coordinated to 4 ring nitrogens; propionyl groups are polar, rest largely hydrophobic.
Hydrophobic pocket + coordination to His F8 (proximal His); this helps prevent Fe²⁺ oxidation.
5th coordination position of Fe²⁺.
6th coordination position of Fe²⁺.
Assists O₂ binding, raises O₂ specificity, lowers CO affinity (improves selectivity).
No; Mb shows constant affinity behavior.
Mb+O 2⇌MbO 2
; at pO₂ = Kd, Mb is 50% saturated (hyperbolic curve).
α₂β₂ heterotetramer; each subunit has heme between E & F helices (like Mb).
Homologous folds (8 α-helices + pocket) with conserved key residues.
Identical core chemistry: O₂ at Fe²⁺(heme); His F8 and His E7 are invariant and critical.
Conservative (e.g., Leu↔Ile) ≈ minor effects; critical (e.g., Ser↔Val) can alter function.
Constant affinity (e.g., Mb).
Cooperative binding with changing affinity (e.g., Hb).
mb:O2 handling within tissues. Hb: O2 transport lungs--> tissues
T (tense, low affinity) and R (relaxed, high affinity); cooperativity enables efficient delivery.
Histidine positions shift at interfaces; central cavity shrinks (R) from larger (T).
Effector binding changes affinity at other sites: homo (same ligand), hetero (different ligand); activators increase, inhibitors decrease affinity.
Homoallosteric activator—binding O₂ promotes more O₂ binding (positive cooperativity).
Fe²⁺ moves into heme plane → His F8 & helix F shift → subunit interfaces change → raise affinity in other subunits (T→R).
Activators shift to higher affinity, inhibitors to lower affinity (O₂ curve remains sigmoidal).
O₂ (homo-activator); 2,3-BPG & H⁺ (hetero-inhibitors for O₂).
Stabilizes T-state, reduces O₂ affinity → enables release in tissues.
Central cavity of deoxy (T) Hb; interacts with positively charged residues (~4 His, 2 Lys, 2 N-termini). The R-state cavity is too small.
Metabolism → H⁺ (ATP hydrolysis, CO₂ hydration). Protonation enhances BPG binding, reduces O₂ affinity; alters subunit interfaces → Bohr effect.
lungs: high PO2 and higher pH (7.6) --> R state, O2 binding
tissues: low pO2 and lower pH (7.2) --> T state, O2 release
O₂, pH (H⁺), and 2,3-BPG together set the T↔R equilibrium to match physiological needs.
Structure absolutely determines function; mutations can be pathogenic (e.g., sickle cell) or adaptive (fetal Hb).
β6 Glu→Val (polar→hydrophobic). In T-state, a hydrophobic patch is exposed; Val fits and promotes polymerization into fibers → sickled cells.
HbF = α₂γ₂; γ ≈ β but His143→Ser reduces BPG binding → higher O₂ affinity (helps extract O₂ from maternal blood).
His F8 (proximal): heme attachment & protects Fe²⁺ from oxidation.
His E7 (distal): assists O₂ binding, lowers CO affinity.
4 His in central cavity: 2,3-BPG binding.
His at interfaces: contribute to T↔R electrostatics.
Hb undergoes T↔R allosteric transitions (cooperativity) modulated by O₂ (homo-activator), H⁺ & 2,3-BPG (hetero-inhibitors); Mb has one site with constant affinity.
